Algestone acetonide: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Synthetic progestin}} | {{Short description|Synthetic progestin}} | ||
{{Drugbox | {{Drugbox | ||
| | | verifiedfields = changed | ||
| verifiedrevid = | | verifiedrevid = 477241679 | ||
| IUPAC_name = (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | |||
| image = Algestone_acetonide.svg | | image = Algestone_acetonide.svg | ||
| width = 200px | |||
| image2 = Algestone_acetonide.svg | | image2 = Algestone_acetonide.svg | ||
| width2 = 200px | |||
}} | }} | ||
'''Algestone acetonide''' is a synthetic [[progestin]] | '''Algestone acetonide''' is a synthetic [[progestin]] of the [[pregnane]] group, which is used in [[hormonal contraception]] and [[hormone replacement therapy]]. It is a derivative of [[algestone]], also known as 16α,17α-dihydroxyprogesterone, and is used in combination with [[estrogens]] for various therapeutic purposes. | ||
==Chemical Structure== | ==Chemical Structure== | ||
[[File:Algestone_acetonide.svg|Chemical structure of Algestone acetonide|thumb|right]] | [[File:Algestone_acetonide.svg|Chemical structure of Algestone acetonide|thumb|right]] | ||
Algestone acetonide is a [[steroid]] with a | Algestone acetonide is a [[steroid]] with a chemical structure that includes a [[cyclopentanoperhydrophenanthrene]] ring system. It is characterized by the presence of an acetonide group at the 16α,17α positions, which enhances its [[lipophilicity]] and [[bioavailability]]. | ||
==Pharmacology== | ==Pharmacology== | ||
Algestone acetonide acts | Algestone acetonide acts as a potent [[agonist]] of the [[progesterone receptor]]. It exerts its effects by binding to the receptor, leading to changes in the expression of [[genes]] involved in the regulation of the [[menstrual cycle]] and [[pregnancy]]. | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
The | The primary mechanism of action of algestone acetonide is the inhibition of [[ovulation]]. It suppresses the secretion of [[gonadotropins]] from the [[pituitary gland]], thereby preventing the maturation and release of [[ovum|ova]] from the [[ovaries]]. | ||
===Pharmacokinetics=== | |||
Algestone acetonide is administered via [[intramuscular injection]] or [[topical application]]. It is metabolized in the [[liver]] and excreted primarily in the [[urine]]. The acetonide group contributes to its prolonged duration of action. | |||
==Clinical Uses== | ==Clinical Uses== | ||
Algestone acetonide is used in | Algestone acetonide is used in combination with [[estrogens]] in [[contraceptive]] formulations. It is also employed in the management of [[menstrual disorders]] and as part of [[hormone replacement therapy]] in [[postmenopausal]] women. | ||
==Side Effects== | ==Side Effects== | ||
Common side effects of algestone acetonide include [[nausea]], [[headache]], [[breast tenderness]], and [[mood changes]]. Long-term use may be associated with an increased risk of [[thromboembolic events]]. | Common side effects of algestone acetonide include [[nausea]], [[headache]], [[breast tenderness]], and [[mood changes]]. Long-term use may be associated with an increased risk of [[thromboembolic events]]. | ||
==Related Compounds== | ==Related Compounds== | ||
Algestone acetonide is related to other synthetic progestins such as [[medroxyprogesterone acetate]] and [[ | Algestone acetonide is related to other synthetic progestins such as [[medroxyprogesterone acetate]] and [[norethisterone]]. These compounds share similar mechanisms of action but differ in their chemical structures and pharmacokinetic profiles. | ||
==Related Pages== | ==Related Pages== | ||
* [[ | * [[Progestin]] | ||
* [[Hormonal contraception]] | * [[Hormonal contraception]] | ||
* [[Hormone replacement therapy]] | * [[Hormone replacement therapy]] | ||
* [[ | * [[Menstrual cycle]] | ||
[[Category:Progestogens]] | [[Category:Progestogens]] | ||
[[Category:Steroids]] | [[Category:Steroids]] | ||
[[Category:Hormonal contraception]] | [[Category:Hormonal contraception]] | ||
Latest revision as of 17:02, 5 March 2025
Synthetic progestin
| Algestone acetonide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Algestone acetonide is a synthetic progestin of the pregnane group, which is used in hormonal contraception and hormone replacement therapy. It is a derivative of algestone, also known as 16α,17α-dihydroxyprogesterone, and is used in combination with estrogens for various therapeutic purposes.
Chemical Structure[edit]
Algestone acetonide is a steroid with a chemical structure that includes a cyclopentanoperhydrophenanthrene ring system. It is characterized by the presence of an acetonide group at the 16α,17α positions, which enhances its lipophilicity and bioavailability.
Pharmacology[edit]
Algestone acetonide acts as a potent agonist of the progesterone receptor. It exerts its effects by binding to the receptor, leading to changes in the expression of genes involved in the regulation of the menstrual cycle and pregnancy.
Mechanism of Action[edit]
The primary mechanism of action of algestone acetonide is the inhibition of ovulation. It suppresses the secretion of gonadotropins from the pituitary gland, thereby preventing the maturation and release of ova from the ovaries.
Pharmacokinetics[edit]
Algestone acetonide is administered via intramuscular injection or topical application. It is metabolized in the liver and excreted primarily in the urine. The acetonide group contributes to its prolonged duration of action.
Clinical Uses[edit]
Algestone acetonide is used in combination with estrogens in contraceptive formulations. It is also employed in the management of menstrual disorders and as part of hormone replacement therapy in postmenopausal women.
Side Effects[edit]
Common side effects of algestone acetonide include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of thromboembolic events.
Related Compounds[edit]
Algestone acetonide is related to other synthetic progestins such as medroxyprogesterone acetate and norethisterone. These compounds share similar mechanisms of action but differ in their chemical structures and pharmacokinetic profiles.
